Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
September 30, 2026 -6.689M
June 30, 2026 -5.497M
March 31, 2026 -6.17M
December 31, 2025 -6.255M
September 30, 2025 -7.514M
June 30, 2025 -7.561M
March 31, 2025 -4.139M
December 31, 2024 -5.331M
September 30, 2024 -5.587M
June 30, 2024 -6.85M
March 31, 2024 -12.43M
December 31, 2023 45.25M
September 30, 2023 87.97M
June 30, 2023 102.56M
March 31, 2023 121.68M
December 31, 2022 66.89M
September 30, 2022 42.24M
June 30, 2022 30.45M
March 31, 2022 14.86M
December 31, 2021 14.86M
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
Date Value
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -0.128M
September 30, 2015 -0.253M
June 30, 2015 -0.368M
March 31, 2015 -0.501M
December 31, 2014 -0.496M
September 30, 2014 -0.50M
June 30, 2014 -0.385M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
AVITA Medical, Inc. 69.75M
Agenus, Inc. 131.74M
Amgen, Inc. 28.84B
Anika Therapeutics, Inc. 78.26M
BioCryst Pharmaceuticals, Inc. 938.98M